The SQ HDM Slit-Tablet Reduces Symptoms of House Dust Mite Allergic Rhinitis in Adolescents; A Subgroup Analysis of Results from a Dbpc Phase III Trial (TO-203-3-2)

      The SQ house dust mite (HDM) SLIT-tablet is an allergy immunotherapy tablet approved in Europe (treatment of HDM allergic rhinitis and asthma in adults; ACARIZAX, ALK) and Japan (treatment of HDM allergic rhinitis in adults and adolescents; Miticure, TORII). HDM allergy is frequent among children and adolescents and allergy immunotherapy a relevant treatment option.
      To read this article in full you will need to make a payment


      Subscribe to Journal of Allergy and Clinical Immunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect